Literature DB >> 31865789

Endoplasmic Reticulum Chaperone Calmegin Is Upregulated in Aldosterone-Producing Adenoma and Associates With Aldosterone Production.

Kiyotaka Itcho1, Kenji Oki1, Celso E Gomez-Sanchez2, Elise P Gomez-Sanchez2, Haruya Ohno1, Kazuhiro Kobuke1, Gaku Nagano1, Yoko Yoshii1, Ryuta Baba1, Noboru Hattori1, Masayasu Yoneda1.   

Abstract

The endoplasmic reticulum (ER) plays a pivotal role in syntheses of proteins and steroid hormones and regulation of intracellular Ca2+ level. We aimed to investigate ER-associated genes in aldosterone-producing adenomas (APAs) and clarify their effect on aldosterone production. Microarray analysis targeting 288 ER-associated genes was conducted using nonfunctioning adrenocortical adenomas (n=5) and APAs (n=19). Immunohistochemistry and quantitative polymerase chain reaction analyses were performed with 13 nonfunctioning adrenocortical adenoma and 48 APA samples. Functional studies were performed with human adrenocortical carcinoma (HAC15) cells, some of which were genetically modified using lentiviruses. The ER chaperone calmegin (CLGN) was the most highly expressed ER-associated gene in APAs relative to nonfunctioning adrenocortical adenomas. Analysis with quantitative polymerase chain reaction revealed CLGN to be 9.5-fold upregulated in APAs relative to nonfunctioning adrenocortical adenomas. There were no differences among different APA genotypes affecting aldosterone production. Immunohistochemistry analysis revealed that CLGN was strongly expressed in APAs and aldosterone-producing cell clusters. Angiotensin II stimulation or KCNJ5 T158A overexpression in HAC15 cells did not affect CLGN mRNA levels. CLGN overexpression in HAC15 cells increased aldosterone levels but did not stimulate CYP11B2 mRNA levels. Pathway and gene ontology analyses using RNA sequencing results showed that tRNA aminoacyl metabolism was the most enriched pathway in CLGN-overexpressing cells. CYP11B2 (aldosterone synthase) and HSD3B2 (3 beta-hydroxysteroid dehydrogenase/delta 5->4-isomerase type 2) protein expression were more abundant in CLGN-overexpressing cells. CLGN knockdown using CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/clustered regularly interspaced short palindromic repeat-associated 9) method in HAC15 cells that carry the KCNJ5 mutation did not affect aldosterone production. To summarize, CLGN was upregulated and associated with aldosterone production via translational regulation of CYP11B2 in APAs.

Entities:  

Keywords:  adenoma; aldosterone; blood pressure; gene ontology; hyperaldosteronism

Mesh:

Substances:

Year:  2019        PMID: 31865789      PMCID: PMC7004827          DOI: 10.1161/HYPERTENSIONAHA.119.14062

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  31 in total

1.  Long-term cardio- and cerebrovascular events in patients with primary aldosteronism.

Authors:  Paolo Mulatero; Silvia Monticone; Chiara Bertello; Andrea Viola; Davide Tizzani; Andrea Iannaccone; Valentina Crudo; Jacopo Burrello; Alberto Milan; Franco Rabbia; Franco Veglio
Journal:  J Clin Endocrinol Metab       Date:  2013-09-20       Impact factor: 5.958

2.  Aberrant G protein-receptor expression is associated with DNA methylation in aldosterone-producing adenoma.

Authors:  Kiyotaka Itcho; Kenji Oki; Kazuhiro Kobuke; Yoko Yoshii; Haruya Ohno; Masayasu Yoneda; Noboru Hattori
Journal:  Mol Cell Endocrinol       Date:  2017-09-07       Impact factor: 4.102

3.  Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.

Authors:  Paul Milliez; Xavier Girerd; Pierre-François Plouin; Jacques Blacher; Michel E Safar; Jean-Jacques Mourad
Journal:  J Am Coll Cardiol       Date:  2005-04-19       Impact factor: 24.094

Review 4.  Diversity and selectivity in mRNA translation on the endoplasmic reticulum.

Authors:  David W Reid; Christopher V Nicchitta
Journal:  Nat Rev Mol Cell Biol       Date:  2015-03-04       Impact factor: 94.444

Review 5.  Evolution of the multi-tRNA synthetase complex and its role in cancer.

Authors:  Do Young Hyeon; Jong Hyun Kim; Tae Jin Ahn; Yeshin Cho; Daehee Hwang; Sunghoon Kim
Journal:  J Biol Chem       Date:  2019-02-19       Impact factor: 5.157

6.  Development of monoclonal antibodies against human CYP11B1 and CYP11B2.

Authors:  Celso E Gomez-Sanchez; Xin Qi; Carolina Velarde-Miranda; Maria W Plonczynski; C Richard Parker; William Rainey; Fumitoshi Satoh; Takashi Maekawa; Yasuhiro Nakamura; Hironobu Sasano; Elise P Gomez-Sanchez
Journal:  Mol Cell Endocrinol       Date:  2013-12-08       Impact factor: 4.102

7.  Hypomethylation of CYP11B2 in Aldosterone-Producing Adenoma.

Authors:  Yoko Yoshii; Kenji Oki; Celso E Gomez-Sanchez; Haruya Ohno; Kiyotaka Itcho; Kazuhiro Kobuke; Masayasu Yoneda
Journal:  Hypertension       Date:  2016-10-17       Impact factor: 10.190

8.  Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome.

Authors:  Felix Beuschlein; Martin Fassnacht; Guillaume Assié; Davide Calebiro; Constantine A Stratakis; Andrea Osswald; Cristina L Ronchi; Thomas Wieland; Silviu Sbiera; Fabio R Faucz; Katrin Schaak; Anett Schmittfull; Thomas Schwarzmayr; Olivia Barreau; Delphine Vezzosi; Marthe Rizk-Rabin; Ulrike Zabel; Eva Szarek; Paraskevi Salpea; Antonella Forlino; Annalisa Vetro; Orsetta Zuffardi; Caroline Kisker; Susanne Diener; Thomas Meitinger; Martin J Lohse; Martin Reincke; Jérome Bertherat; Tim M Strom; Bruno Allolio
Journal:  N Engl J Med       Date:  2014-02-26       Impact factor: 91.245

9.  Development of an adrenocorticotropin-responsive human adrenocortical carcinoma cell line.

Authors:  Jeniel Parmar; Rebecca E Key; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2008-08-19       Impact factor: 5.958

10.  Calmodulin-dependent kinase I regulates adrenal cell expression of aldosterone synthase.

Authors:  Jennifer C Condon; Vincenzo Pezzi; Brad M Drummond; Su Yin; William E Rainey
Journal:  Endocrinology       Date:  2002-09       Impact factor: 4.736

View more
  7 in total

1.  Association of DNA methylation with steroidogenic enzymes in Cushing's adenoma.

Authors:  Takaya Kodama; Kenji Oki; Yu Otagaki; Ryuta Baba; Akira Okada; Kiyotaka Itcho; Kazuhiro Kobuke; Gaku Nagano; Haruya Ohno; Nobuyuki Hinata; Koji Arihiro; Celso E Gomez-Sanchez; Masayasu Yoneda; Noboru Hattori
Journal:  Endocr Relat Cancer       Date:  2022-06-29       Impact factor: 5.900

Review 2.  The landscape of molecular mechanism for aldosterone production in aldosterone-producing adenoma.

Authors:  Kenji Oki; Celso E Gomez-Sanchez
Journal:  Endocr J       Date:  2020-09-24       Impact factor: 2.860

3.  Hypomethylation associated vitamin D receptor expression in ATP1A1 mutant aldosterone-producing adenoma.

Authors:  Yuta Nanao; Kenji Oki; Kazuhiro Kobuke; Kiyotaka Itcho; Ryuta Baba; Takaya Kodama; Yu Otagaki; Akira Okada; Yoko Yoshii; Gaku Nagano; Haruya Ohno; Koji Arihiro; Celso E Gomez-Sanchez; Noboru Hattori; Masayasu Yoneda
Journal:  Mol Cell Endocrinol       Date:  2022-03-04       Impact factor: 4.369

4.  Genotype-specific cortisol production associated with Cushing's syndrome adenoma with PRKACA mutations.

Authors:  Ryuta Baba; Kenji Oki; Celso E Gomez-Sanchez; Yu Otagaki; Kiyotaka Itcho; Kazuhiro Kobuke; Takaya Kodama; Gaku Nagano; Haruya Ohno; Masayasu Yoneda; Noboru Hattori
Journal:  Mol Cell Endocrinol       Date:  2021-09-11       Impact factor: 4.102

Review 5.  Update on Genetics of Primary Aldosteronism.

Authors:  Kiyotaka Itcho; Kenji Oki; Haruya Ohno; Masayasu Yoneda
Journal:  Biomedicines       Date:  2021-04-10

6.  ATP1A1 Mutant in Aldosterone-Producing Adenoma Leads to Cell Proliferation.

Authors:  Kazuhiro Kobuke; Kenji Oki; Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Kiyotaka Itcho; Haruya Ohno; Gaku Nagano; Yoko Yoshii; Ryuta Baba; Takaya Kodama; Koji Arihiro; Noboru Hattori; Masayasu Yoneda
Journal:  Int J Mol Sci       Date:  2021-10-12       Impact factor: 5.923

Review 7.  Primary aldosteronism: Pathophysiological mechanisms of cell death and proliferation.

Authors:  Martina Tetti; Siyuan Gong; Franco Veglio; Martin Reincke; Tracy Ann Williams
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-08       Impact factor: 6.055

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.